Previously, CSCs in RCC have been identified by using either stem cell markers [CD133, CD44, CXCR4, CD105 and Spalt-Like Transcription Factor 4 (SALL4)] [9–13] or functional assays (sphere-forming ability, side population and ALDH activity) [14–16]. The gene discussed is LDHA; the disease is renal cell carcinoma.